Distinctive gene transduction efficiencies of commonly used viral vectors in the retina

Current Eye Research
Shenghai Zhang Qian-Huang

Abstract

The transduction efficiency and cell tropism of viral vectors rAAV2/1, rAAV2, Ad5, Ad5/F35, and Lentivirus were evaluated in retina. All viral vectors achieved efficient transduction in living rat retina. However, each vector showed distinctive efficiency in vitro especially for rAAV2/1, which displayed poor transduction in cultured retinal cells. Distinctive cell-specific GFP expression was observed in vivo and in vitro for the same viral vector. The cell-specific tropism was not strictly correlated with the correspondent distribution of viral receptors in retina. These results provided important insights into the selection of appropriate vectors when specific retinal diseases are considered for gene therapy.

References

Aug 1, 1982·Experimental Eye Research·L E Stramm, E L Pautler
Apr 17, 1998·Current Eye Research·E Anglade, K G Csaky
Oct 10, 1998·Journal of Virology·T DullL Naldini
Jan 12, 1999·Nature Medicine·C SummerfordR J Samulski
Feb 3, 2000·The New England Journal of Medicine·G L King, K Suzuma
Oct 16, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ghislaine DuisitFabienne Rolling
Nov 5, 2002·Methods : a Companion to Methods in Enzymology·Keith R G MartinHarry A Quigley
Dec 4, 2002·Journal of Cellular Biochemistry·Edward Chaum
Apr 14, 2004·Archives of Ophthalmology·Nathan CongdonUNKNOWN Eye Diseases Prevalence Research Group
May 27, 2004·Investigative Ophthalmology & Visual Science·Joshua N MallamRichard L Hurwitz
Jun 15, 2005·Annual Review of Biochemistry·Inder M Verma, Matthew D Weitzman
Jun 18, 2005·Human Gene Therapy·Astra DinculescuWilliam W Hauswirth
Jun 25, 2005·Current Gene Therapy·Alberto Auricchio, Fabienne Rolling
Nov 1, 2005·Expert Opinion on Biological Therapy·Chris Thanos, Dwaine Emerich
Dec 20, 2005·The Journal of Pathology·Lawrence S YoungVivien Mautner
Feb 8, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nelson DiPaoloAndré Lieber
Feb 10, 2006·Cell Research·Xin Yuan Liu, Jin Fa Gu
Feb 16, 2006·Current Gene Therapy·Romain R VivèsPascal Fender
Jul 14, 2006·Gene Therapy·J W B BainbridgeR R Ali
May 26, 2007·Human Gene Therapy·Nicola J Philpott, Adrian J Thrasher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.